Research & development > Clinical diagnostics

New liquid biopsy method detects early kidney cancer

29 June, 2020

The method has been found to detect kidney cancers with high accuracy, including small, localised tumours for which no early detection method currently exists.


New test improves early detection of prostate cancer

17 June, 2020

A groundbreaking new test can improve the early detection of prostate cancer compared with the existing prostate-specific antigen (PSA) blood test.


Saliva tests for COVID-19 could replace nasal swabs

04 June, 2020

Saliva can be used to diagnose the presence and transmission of COVID-19, and to monitor immunity to SARS-Cov-2.


Biomarker signature found for tuberculosis infection

21 May, 2020

The biomarker discovery could be used as the basis for a highly effective and simple diagnostic blood test to help detect prevalent cases of TB in the community.


Diagnostic test tracks the spread of infectious diseases

14 May, 2020

The new diagnostic approach has the potential to enhance infectious diseases surveillance, and so is now being adapted to track immunity to COVID-19.


Fighting the COVID-19 fire with molecular diagnostics innovations

04 May, 2020 by Dr Luyun Jiang, Technology Analyst

Unlike in the influenza pandemic in 1918, today we are better equipped to identify the elusive bug responsible for COVID-19.


Biomarkers for urological cancers found in urine

22 April, 2020

Researchers have developed a new method to enable more timely diagnosis and treatment of urological cancers, ie, prostate, bladder and kidney cancers.


AI blood test can detect over 50 types of cancer

15 April, 2020

A new blood test can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms.


POC infection diagnosis combats antibiotic resistance

11 March, 2020

A new infection test, made up of sheets of paper patterned by lasers, will enable diagnosis at the point of care — helping doctors give patients the right treatment, and quickly.


Gold nanoparticles used to detect cancer

04 March, 2020

The nanotechnology developed by University of Queensland scientists can detect and monitor extracellular vesicles (EVs) in the bloodstream.


Chest CT scans recommended for COVID‑19 screening

02 March, 2020

Computed tomography (CT) of the chest demonstrates better sensitivity than reverse-transcription polymerase chain reaction (RT‑PCR) when it comes to diagnosing COVID‑19.


Rapid diagnostic test for Ebola under development

26 February, 2020

The test will detect the infection early in blood by embedding monoclonal antibodies against surface glycoproteins (GP) — one of the first detectable biomarkers of infection.


Saliva test offers easier detection of mouth and throat cancer

13 January, 2020

A novel non-invasive technique can successfully detect human papilloma virus-16 — the strain associated with oropharyngeal cancer — in saliva samples.


Rapid asthma diagnosis with a drop of blood

12 December, 2019

A new rapid test is expected to return a finding after just 60 to 90 min — and all it requires to diagnose asthma is a drop of blood and the immune cells it contains.


Home urine test helps diagnose aggressive prostate cancer

11 December, 2019

The urine test diagnoses aggressive prostate cancer and predicts whether patients will require treatment up to five years earlier than standard clinical methods.


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd